Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Cécile Lugagne"'
Autor:
Thierry Rème, François Romagne, Maud Condomines, Bernard Klein, Philippe Quittet, Jean François Rossi, Cécile Lugagne, Z. Y. Lu, Maka Burjanadzé, Pascal Latry, Yanis Morel
Publikováno v:
British Journal of Haematology. 139:206-216
T-cell-mediated immunotherapy is a promising therapeutic option for multiple myeloma (MM). Gamma-delta T cells (gammadelta T cells) recognize phosphoantigens and display strong anti-tumour cytotoxicity. The synthetic agonist Phosphostim (bromohydrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fea8330578ccf7ccbddec56777ce69
https://doi.org/10.1111/j.1365-2141.2007.06754.x
https://doi.org/10.1111/j.1365-2141.2007.06754.x
Autor:
Bernard Klein, Tarik Kanouni, Maud Condomines, Marion Larroque, Cécile Lugagne, Jean-François Rossi, Jean-Luc Veyrune, Pascal Latry, Catherine Hertogh, Philippe Quittet
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2010, 184 (2), pp.1079-84. ⟨10.4049/jimmunol.0804159⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2010, 184 (2), pp.1079-84. ⟨10.4049/jimmunol.0804159⟩
High-dose melphalan (HDM) followed by autologous stem cell transplantation (ASCT) is a standard treatment for patients with multiple myeloma. However, lymphocyte reconstitution is impaired after HDM. Recent work has suggested that the lymphopenia per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462a0b3547620606a93fe7bdf2193a4d
https://www.hal.inserm.fr/inserm-00450270/document
https://www.hal.inserm.fr/inserm-00450270/document
